{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Des Plaines",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "93230",
      "recalling_firm": "Abbott Molecular, Inc.",
      "address_1": "1300 E Touhy Ave",
      "address_2": "",
      "postal_code": "60018-3315",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Worldwide",
      "recall_number": "Z-0407-2024",
      "product_description": "Alinity m HCV AMP kit, List (REF) Numbers:  a) 08N50-095 and b) 08N50-090. The Alinity m HCV assay is an in vitro reverse transcription-polymerase chain reaction (RT-PCR) assay for use with the automated Alinity m System to detect and quantitate hepatitis C virus (HCV) RNA in human serum or plasma.",
      "product_quantity": "1,881 units",
      "reason_for_recall": "Abbott has received reports of an increase in reactive negative controls and false positive results in patient samples when using the Identified Lots of Alinity m HCV AMP Kit.",
      "recall_initiation_date": "20231030",
      "center_classification_date": "20231129",
      "report_date": "20231206",
      "code_info": "a) 08N50-095:  UDI/DI 00884999047648, Lot Numbers:  381582, 382448, 383204;   b) 08N50-090:  UDI/DI 00884999047761, Lot Numbers:  383203, 385720, 381581, 382447",
      "more_code_info": ""
    }
  ]
}